In Pilot Study,Peptide Controls Blood Sugar in People with Congenital Hyperinsulinism

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
Children's Hospital of Philadelphia Researchers Develop First Potential Medicine for Patients with Most Severe Form of this Disease--

A pilot study in adolescents and adults has found that an investigational drug shows promise as the first potential medical treatment for children with the severest type of congenital hyperinsulinism, a rare but potentially devastating disease in which gene mutations cause insulin levels to become dangerously high.

"There is currently no effective medicine for children with the most common and most severe form of hyperinsulinism," said study leader Diva D. De Leon, M.D., a pediatric endocrinologist at The Children's Hospital of Philadelphia. "Our new research shows that this investigational drug, a peptide called exendin-(9-39), controls blood sugar levels in people, a very promising result."

http://www.marketwatch.com/story/in...le-with-congenital-hyperinsulinism-2012-08-01
 
Status
Not open for further replies.
Back
Top